Patents Assigned to Ovita Limited
  • Publication number: 20100235930
    Abstract: The present invention is directed to a method of selecting animals that are genetically resistant to one or more intestinal parasite infections by testing mucus samples for the presence of an antibody against one or more of said intestinal parasites and segregation and selecting the animals that test positive. The animals that test negative are less parasite resistant and can be subjected to parasite management regimes.
    Type: Application
    Filed: June 12, 2008
    Publication date: September 16, 2010
    Applicant: OVITA LIMITED
    Inventors: Richard John Shaw, Merie Christine Cannon, Sarah Margaret Rosanowski, Mary Wheeler, Christopher Anthony Morris
  • Publication number: 20080286817
    Abstract: The present invention is related to novel nucleotide sequences encoding a louse allergen and a methods for diagnosing, treating and preventing lice infestation and associated allergic disease with the nucleotide sequences and protein allergen of the invention. The present invention also relates to kits for diagnostic assays.
    Type: Application
    Filed: November 9, 2007
    Publication date: November 20, 2008
    Applicant: OVITA LIMITED
    Inventors: Alexander Terrance Pfeffer, Charles Bix Shoemaker
  • Patent number: 7326774
    Abstract: The present invention relates to an isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3. It also relates to the antigen which binds to the monoclonal antibody and uses for the monoclonal antibody and antigen in diagnosing and treating or preventing nematode infection.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: February 5, 2008
    Assignee: Ovita Limited
    Inventors: Gavin Bernard Lear Harrison, Wayne Robert Hein, Hugh Douglas Pulford, Charles Bix Shoemaker
  • Patent number: 7294477
    Abstract: The present invention is related to novel nucleoli sequences encoding a louse allergen and a methods for diagnosing, treating and preventing lice infestation and associated allergic disease with the nucleoli sequences and protein allergen of the invention. The present invention also relates to kits for diagnostic assays.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: November 13, 2007
    Assignee: Ovita Limited
    Inventors: Alexander Terrance Pfeffer, Charles Bix Shoemaker
  • Patent number: 6994999
    Abstract: The present invention relates to a novel promoter sequence which encodes an isolated DNA molecule comprising the polynucleotide sequence of SEQ ID NO: 1 and which encodes the promoter region of the myostatin gene, or a fragment thereof, or variant thereof which has been modified by the insertion, substitution or deletion of one or more nucleotides, said fragment and variant of said polynucleotide sequence having substantially equivalent function thereto.
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: February 7, 2006
    Assignee: Ovita Limited
    Inventors: James J. Bass, Ferenc Jeanplong, Ravi Kambadur, Mridula Sharma
  • Publication number: 20050180978
    Abstract: The present invention relates to an isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3. It also relates to the antigen which binds to the monoclonal antibody and uses for the monoclonal antibody and antigen in diagnosing and treating or preventing nematode infection.
    Type: Application
    Filed: January 30, 2003
    Publication date: August 18, 2005
    Applicants: OVITA LIMITED, AgResearch Limited
    Inventors: Gavin Harrison, Wayne Hein, Hugh Pulford, Charles Shoemaker